Email this article 
Hide
Show all
Lessons from the Field
Strengthening laboratory capacity for detection of respiratory viral pathogens through the Global Health Security Agenda (GHSA) framework
Submitted: 10 July 2018 | Published: 18 July 2019
About the author(s)
Brett Whitaker, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United StatesKaren A. Alroy, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Erica Guthrie, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Sarah Schildecker, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Susan Hiers, Office of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Jill Woodard, Office of the Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
S. Arunmozhi Balajee, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States
Abstract
Background: Endemic and emerging respiratory viruses are a threat to public health, and a robust public health laboratory system is essential to ensure global health security.
Objective: This program sought to expand molecular laboratory testing capacity to detect a broad range of respiratory pathogens in clinical respiratory specimens collected during disease surveillance and outbreak investigations.
Methods: As a part of the Global Health Security Agenda (GHSA), the United States Centers for Disease Control and Prevention utilised the equipment and training infrastructure already in place at the World Health Organization National Influenza Centers to expand testing capacity for respiratory viruses in laboratories in GHSA partner countries. This was done through the provision of quality assured reagents, including multiplex platforms and technical guidance for laboratory staff, as well as the assessment of laboratory testing accuracy.
Conclusion: Early findings illustrated that GHSA laboratories have been able to expand testing capacity using specimens from routine surveillance, as well as from outbreak situations.
Keywords
Metrics
Total abstract views: 4581Total article views: 5805
Crossref Citations
1. The Importance of Intra- and Inter-Institutional Networks for Capacity Building in Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription Polymerase Chain Reaction Services: Experience from an Oncology Centre in Eastern India
Deepak Kumar Mishra, Gaurav Goel, Neeraj Arora, Shekhar Krishnan, Sanjay Bhattacharya, Purva Mathur, Kamini Walia, Mammen Chandy
Indian Journal of Medical Microbiology vol: 38 issue: 1 first page: 9 year: 2020
doi: 10.4103/ijmm.IJMM_20_255
2. Prevalence of respiratory tract infections and influencing factors: A cross‐sectional survey in Anhui Province, China
Ting Zhu, Pinglan Zhang, Xingrong Shen, Jing Cheng, Jing Chai, Rui Feng, Debin Wang
Public Health Nursing vol: 38 issue: 4 first page: 542 year: 2021
doi: 10.1111/phn.12874
3. Incidence, risk factors, and viral etiology of community-acquired acute lower respiratory tract infection among older adults in rural north India
Rakesh Kumar, Lalit Dar, Ritvik Amarchand, Siddhartha Saha, Kathryn E Lafond, Debjani R Purakayastha, Ramesh Kumar, Avinash Choudekar, Giridara Gopal, Shivram Dhakad, Venkatesh Vinayak Narayan, Abhishek Wahi, Reshmi Chhokar, Stephen Lindstrom, Brett Whitaker, Aashish Choudhary, A B Dey, Anand Krishnan
Journal of Global Health vol: 11 year: 2021
doi: 10.7189/jogh.11.04027